TE_6076
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 366.31 |
| Counts of samples | TCGA_tumor:324; TCGA_normal:0; GTEx:0 |
| TSS | chr2(-):147727390 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_6076.1 | - | Intergenic | Non-coding | Non-coding | chr2(-):147675557,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.2 | - | Intergenic | Non-coding | Non-coding | chr2(-):147578254,147578274,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.3 | - | Intergenic | Non-coding | Non-coding | chr2(-):147389811,147389831,147390536,147391995,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.4 | - | Intergenic | Non-coding | Non-coding | chr2(-):147558228,147558248,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.5 | - | Intergenic | Non-coding | Non-coding | chr2(-):147389811,147389831,147390536,147390652,147391819,147391995,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.6 | - | Intergenic | Non-coding | Non-coding | chr2(-):147391975,147391995,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.7 | - | Intergenic | Non-coding | Non-coding | chr2(-):147657354,147657374,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.8 | - | Intergenic | Non-coding | Non-coding | chr2(-):147671328,147671348,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.9 | - | Intergenic | Non-coding | Non-coding | chr2(-):147638765,147638785,147675511,147675577,147677254,147677322,147727264,147727391 |
| teRNA_6076.10 | - | Intergenic | Non-coding | Non-coding | chr2(-):147611749,147611769,147675511,147675577,147677254,147677322,147727264,147727391 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
